Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_assertion type Assertion NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_head.
- NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_assertion wasGeneratedBy ECO_0000203 NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_provenance.
- NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_assertion wasDerivedFrom befree-20140225 NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_provenance.
- NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_assertion SIO_000772 20222126 NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_provenance.
- NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_assertion evidence source_evidence_literature NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_provenance.
- NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_assertion description "[Coadministration of DSS and the TSPO drug ligands PK 11195 or Ro5-4864 increased both the rate of colon ulceration and regeneration, whereas administration of the TSPO drug ligand flunitrazepam partially prevented this pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700315.RAULD9nG51vFXLYIwuN7eFsIHLscBE8VMdTtjfMDckpIY130_provenance.